Datasheet
10 Oct 2022
Overview Available MAs
PDF 8 kB
Available Marketing Authorizations
Content provided by our supplier
Centrient Pharmaceuticals
-
Country/Region:Netherlands
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
Other Content from Centrient Pharmaceuticals (1)
-
News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech
Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).
With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.